/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE
SERVICES OR FOR DISSEMINATION IN THE
UNITED STATES/
OTTAWA, Nov. 7, 2018 /CNW/ - National Access
Cannabis Corp. ("NAC" or the "Company") (TSXV: META) announces
that it has amended and re-filed its unaudited reviewed interim
financial statements and management's discussion and analysis (the
"Filings") for the interim period ended May 31, 2018. The Filings have been amended to
revise the accounting treatment for the acquisition of both
National Access Cannabis Medical Inc. and NAC Bio Inc. The effect
of the amendments to the Filings was to adjust the accounting
treatment to consolidate both entities, adjusting the
non-controlling interest and intangible assets.
About National Access Cannabis Corp.
NAC is a best
practices leader in delivering secure, safe, and responsible access
to legal cannabis in Canada.
Through its Canada-wide network of
medical cannabis clinics, partner pharmacies, NAC Bio Inc.'s
clinical research division, Meta Cannabis Supply Co.™ and NewLeaf
Cannabis™ recreational cannabis retail stores, NAC enables patients
and the public to gain knowledge and access to Canada's network of authorized Licensed
Producers of cannabis. NAC is listed on the TSX Venture Exchange
under the symbol (TSXV: META).
For more information, visit:
www.nationalaccesscannabis.com
www.metacannabis.com
www.newleafcannabis.ca
www.nacmedical.com
www.nacbio.com
Neither the TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE National Access Cannabis Corp.